Dr. Ruiping Song, MD

Dr. Song practices at Einstein Community Health Associates, Inc in Jenkintown, Pennsylvania.

Dr. Song's NPI, 1396938205, was assigned on August 23, 2007. Dr. Song graduated from Beijing Medical University in 1996. Dr. Song holds Pennsylvania license MD437900.

Dr. Song's primary practice is Einstein Community Health Associates, Inc, at 500 Old York Rd, Jenkintown, PA 19046 in Montgomery County. The practice phone is (215) 456-7000.

Dr. Song's primary practice is Einstein Community Health Associates, Inc in Jenkintown, Pennsylvania. Dr. Song is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Phoenix Physical Therapy. Dmand AI also links Dr. Song to 4 more hospitals, 5 hospices, 4 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices, 16 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Song is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Song's licenses on file in 2 states: Pennsylvania and New York.

Dmand AI lists acid reflux, acute kidney failure, acute sinusitis, acute skin infection, adjustment disease, alzheimer's disease, aneurysm and ankle or foot injury among the conditions Dr. Song treats.

CMS data shows 2,008 Medicare services from Dr. Song across 12 procedure codes in 2024, for 435 Medicare patients. Medicare paid $171,997 for them. Every service was in an office.

CMS counts 435 Medicare patients who saw Dr. Song in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 67, with 70% women.

In 2024, Dr. Song wrote 11,907 Medicare Part D claims for 772 patients. 89% of them were for generic drugs. CMS names the drug for 11,102 of them, across 160 drugs with 11 or more claims each, at $579,877 in total drug cost. In 2023, CMS named 9,241 claims across 143 drugs.

Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Song as offering telehealth.

Dmand AI links 9 papers to Dr. Song, published from 2003 to 2025. The most frequent topics are Cells, Cultured, Carbon Monoxide and Caspases. Dr. Song has published most often in J Biol Chem. Dr. Song's most frequent co-authors are Raja S. Mahidhara, MD and Reza R. Zarnegar, DO.

CMS Open Payments shows 14 general payments to Dr. Song from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $195.

Dmand AI lists 3 awards for Dr. Song, most recently NCQA PCMH in 2014.

Dr. Song graduated from Beijing Medical University in 1996.

Dr. Song is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Highmark. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.